Eli Lilly 2009 Annual Report Download - page 142

Download and view the complete annual report

Please find page 142 of the 2009 Eli Lilly annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 172

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172

The two-year PA, granted in 2009, will pay out in January 2011 based on cumulative EPS for 2009 and 2010.
The transitional one-year PA, granted in 2009, paid out in January 2010, and the named executive officers
received the restricted share units shown in the table below. For 2009 performance, payouts were 200 percent of
target. To receive a PA payout, a participant must have remained employed with the company through
December 31, 2009 (except in the case of death, disability, or retirement). In addition, an employee who was an
executive officer at the time of grant and an employee at the time of payout received payment in restricted share
units. No dividends accrue on either PAs or SVAs during the performance period. Non-preferential dividends are
accrued during the PAs’ one-year restriction period and are paid upon vesting. Each executive was awarded the
restricted stock units identified in the table below, and the units will remain restricted (and subject to forfeiture
if the executive resigns) until February 2011, at which time the units will be paid out in the form of shares.
Beginning in 2010, the threshold payout for PAs will be 50 percent of target (rather than zero) and the maximum
payout will be 150 percent of target (rather than 200 percent).
Name Performance Awards Value at Payout
Dr. Lechleiter 207,354 $7,497,921
Dr. Paul 82,942 $2,999,183
Mr. Carmine 82,942 $2,999,183
Mr. Rice 82,942 $2,999,183
Mr. Armitage 55,294 $1,999,431
SVAs granted in 2009 will pay out at the end of the three-year performance period according to the schedule
on page 35 of the “Compensation Discussion and Analysis.”
44
PROXY STATEMENT